Ex Parte DEE et al - Page 8


                Appeal No.  2002-1644                                                   Page 8                
                Application No.  08/602,498                                                                   
                      compositions can be used in … (1) preservatives in food stuffs, (2)                     
                      cosmetic formulations, (3) pharmaceutical formulations (topical,                        
                      parenteral, intramuscular, and intravenous), and (4) veterinary                         
                      formulations, such as teat dips, eye medications, and ear                               
                      medications.”                                                                           
                      In addition, appellants point out (Brief, page 14), Kabara discloses that               
                propylene glycol “should be used at any suitable level, with 5-60% by weight                  
                being preferred, 10-30% being more preferred, and 20-25% being most                           
                preferred.”  Based on this disclosure in Kabara, appellants argue (id.), “[s]uch a            
                broad statement, which can relate to such diverse compositions as cosmetics                   
                and pharmaceutical formulations, does not provide a teaching with respect to                  
                teat dip compositions.”  Instead, appellants argue (Brief, pages 14-15id.), one               
                interested in the art of teat dips, would look to Kabara’s exemplified teat dips              
                (examples 2-4) that contain significantly less propylene glycol than required for             
                the compositions of the claimed methods.  Upon review of the facts in evidence,               
                we are compelled to agree with appellants.  Accordingly, we reverse the rejection             
                of claims 14-16 and 21-24 under 35 U.S.C. § 102(b) as anticipated by Kabara.                  
                THE REJECTION UNDER 35 U.S.C. § 103 over Kabara:                                              
                      According to appellants (Brief, page 4), claims 14-16 will stand or fall                
                separately from claims 21-24.  Therefore, we will limit our discussion to                     
                representative independent claims 14 and 21.  Claims 5 and 16 will stand or fall              
                together with claim 14 and claims 22-24 will stand or fall together with claim 21.            
                In re Young, 927 F.2d 588, 590, 18 USPQ2d 1089, 1091 (Fed. Cir. 1991).                        
                      According to the examiner (Answer, page 4), “[i]t would have been                       
                obvious for one of ordinary skill in the art to [m]odify [Kabara to provide the] …            







Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007